ARCA biopharma, Inc. announced that enrollment has been completed in ASPEN-COVID-19, the Phase 2b clinical trial evaluating rNAPc2 as a potential treatment for patients hospitalized with COVID-19. 160 patients were enrolled at clinical investigative...